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Introduction
Juvenile idiopathic arthritis (JIA) is the most common
chronic rheumatic disease in childhood and the polyarti-
cular subtype is associated with persistent activity and a
low rate of remission. The goal of an early and aggres-
sive treatment is to achieve remission preventing irre-
versible joint destruction and long-term disabilities.
Objectives
1) To assess disease activity in patients with pJIA “under
early therapy with MTX.”
2) To determine predictors of ID in this cohort.
Methods
Clinical charts of 174 pJIA pts (ILAR´01), (1998 -2009)
we reviewed. Inclusion criteria:-pJIA pts under “early”
MTX–follow up “a minimum of 12mo”. Demographic,
clinical, laboratory, and therapeutic variables were ana-
lyzed at disease onset, 12mo and last visit. Functional
disability(CHAQ), damage (JADI Articular score) and
Remission Criteria (Wallace) were properly assesed.
Results
Ninety eight patients were included , 85 girls, (86.7%)
median age at onset 10 years ( IQR :6 -12) ,median dis-
ease duration 60 months ( IQR :36 -74 ) and follow-up
48 months (IQR :24,5 -67) ; 34 pts (34.6%) were RF Posi-
tive. All patients received MTX; 32 /98 (32.6%) reached
ID at amedian follow up time of 12 mo with a CHAQ
mean value 0,37 and a JADI mean value 1,3. Nineteen
out these 32 pts (60%) sustained remission for at least 37
mo. ID was associated with a less time of disease evolu-
tion (p.05), a better function CHAQ (p .05) and less
damage (p .04)A higher prevalence but not significantly
RF titers (40 vs 25%); seronegative ANA titers (60 vs 53)
and RX damage (47 vs 32) were observed in the group of
non responders pts to MTX. On multivariate analysis a
less time of disease evolution was the only predictive risk
factor associated to inactive disease (b 1,01 p .05).
Conclusion
In our series , only 32/98 (32.6%) pJIA pts reached ID ,
this clinical state was sustained in 60% of them longer
than 2 years. A less interval between disease onset and
Mtx start was the only variable predicting inactive disease.
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